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Background:  Carotid intima-media thickness (IMT) and arterial stiffness are valid surrogate markers of subclinical atherosclerosis. The cytokine 
adiponectin and its receptors 1 (ADR1) and 2 (ADR2) comprise a new receptor-ligand system, involved in CAD. In the present study we investigated 
whether ADR1 and 2 mRNA and protein expression are associated with arterial stiffness and carotid IMT in patients with chronic CAD.
Methods:  72 patients with angiographically-proven CAD, aged 59±7years, were enrolled. We measured a) gene expression (mRNA levels) of ADR1 
and 2 on isolated blood monocytes [quantitative real-time PCR], b) ADR1 and 2 protein expression [flow-cytometry], c) serum levels of adiponectin, 
metalloproteinase-9 (MMP-9), d) carotid-femoral artery pulse wave velocity (PWV), an index of arterial stiffness, e) mean IMT in both carotid arteries.
Results:  Patients with 1-vessel disease did not differ from those with multi-vessel (2-or 3-vessel) disease in terms of adiponectin, MMP-9, ADR1 
and ADR2 gene and protein expression (p>0.05). Both groups had similar atherosclerotic risk factors. Both ADR1 and ADR2 mRNA were associated 
with PWV (r=0.36 and r=0.34, p<0.05 respectively). ADR1, ADR2 protein and adiponectin were positively correlated with PWV (p<0.05). In multiple 
regression analysis including age, sex, multivessel CAD and risk factors, both ADR1 and ADR2 mRNA remained independent determinants of PWV 
(R2=0.21, p=0.04). MMP9 levels were related with increased ADR2 mRNA and protein as well as increased PWV (r=0.21, r=0.19 and r=0.34, p<0.05 
respectively). We also found a significant correlation of carotid bulb IMT with MMP-9 (r=0.28, p=0.03), ADR2 mRNA (r=0.34, p=0.04) and its protein 
expression (r=0.38, p=0.02).
Conclusions:  Increased gene and protein expression of ADR1 and ADR2 receptors on monocytes is related to arterial stiffness and peripheral 
vascular atherosclerosis in patients with CAD. The interrelation of elevated MMP-9 with increased PWV, carotid IMT and ADR2 expression suggests a 
compensatory increase of the adiponectin receptors against the low grade inflammation within arterial wall in patients with chronic CAD, providing a 
potential therapeutic target.
